APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 67 filers reported holding APTEVO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $188,000 | +123.8% | 288,740 | +100.0% | 0.00% | – |
| Q3 2019 | $84,000 | -33.9% | 144,370 | 0.0% | 0.00% | – |
| Q2 2019 | $127,000 | +24.5% | 144,370 | +26.2% | 0.00% | – |
| Q1 2019 | $102,000 | -64.8% | 114,442 | -50.0% | 0.00% | – |
| Q4 2018 | $290,000 | -50.1% | 228,884 | +100.0% | 0.00% | – |
| Q3 2018 | $581,000 | +5.3% | 114,442 | +3.4% | 0.00% | – |
| Q2 2018 | $552,000 | +75.8% | 110,643 | +14.9% | 0.00% | – |
| Q1 2018 | $314,000 | -23.0% | 96,321 | 0.0% | 0.00% | – |
| Q4 2017 | $408,000 | +85.5% | 96,321 | 0.0% | 0.00% | – |
| Q3 2017 | $220,000 | +10.6% | 96,321 | 0.0% | 0.00% | – |
| Q2 2017 | $199,000 | -22.6% | 96,321 | -23.0% | 0.00% | – |
| Q1 2017 | $257,000 | -4.8% | 125,158 | +13.0% | 0.00% | – |
| Q4 2016 | $270,000 | +4.2% | 110,770 | +9.4% | 0.00% | – |
| Q3 2016 | $259,000 | – | 101,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HighVista Strategies LLC | 196,600 | $981,000 | 0.44% |
| Sessa Capital IM, L.P. | 519,894 | $2,594,000 | 0.26% |
| Alambic Investment Management, L.P. | 116,427 | $581,000 | 0.16% |
| Park West Asset Management LLC | 500,000 | $2,495,000 | 0.09% |
| EAM Investors, LLC | 110,584 | $552,000 | 0.09% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $232,473,000 | 0.08% |
| Spark Investment Management LLC | 135,600 | $676,000 | 0.04% |
| CSS LLC/IL | 118,736 | $592,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 172,639 | $874,000 | 0.02% |
| SFMG, LLC | 15,544 | $78,000 | 0.01% |